Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Kim Wolff
The Enhanced Games miss the point: science can clean up sport
Credit: Tom Weller/DeFodi Images via Getty Can the boundaries of human performance be pushed through science and technology? That’s what tech entrepreneur Aron D’Souza set out to test by founding the Enhanced Games — a sporting event that will permit, even encourage, athletes to use drugs to enhance their prowess. On 24 May in Las Vegas, Nevada, around 50 athletes are set to compete in swimming, athletics and weightlifting, unbound by normal anti-doping rules.
A summer of success for King's Forensics
With its strong scientific credentials, King’s Forensics has a reputation for exceptional research and output that directly tackles some of the big issues in the criminal and legal world. This summer has been no exception, as King’s Forensics has continued to operate at the forefront of evidential analysis. Here are just some of the highlights from King’s Forensics’ summer of success.
Drug Control Centre prepares for Birmingham 2022 Commonwealth Games
The Drug Control Centre (DCC), a part of King’s Forensics at King’s College London, is pleased to provide support to UK Anti-Doping (UKAD) for the Birmingham 2022 Commonwealth Games. The DCC is the UK’s only World Anti-Doping Agency (WADA) accredited lab and will work in partnership with UKAD, the Commonwealth Games Federation (CGF) and Birmingham 2022, to deliver a comprehensive anti-doping programme during the Games.
Leading the international effort against doping in sports
The Drug Control Centre (DCC) is King’s flagship anti-doping laboratory with IEC/ISO 17025 accreditation. The laboratory sits within King’s Forensics, in the Department of Analytical, Environmental & Forensic Sciences (AEFS) and brings together experts of analytical chemistry and bioanalytical research into drug metabolism and the detection of substances used to enhance sporting performance.
How King's has made roads safer from drink- and drug-drivers in England and Wales
The strength of our forensic science and analytical toxicology researchers has proven influential in our understanding of road safety. Our academics and scientists have a long and committed history of working with the Department for Transport (DfT) Drink and Drug Driving Policy Unit, improving road safety policy to be in line with King’s cutting-edge science. One example is found in the contributions to the ‘fit to drive’ scheme for re-licensing high-risk drink-drive offenders (HROs).
Milestone reached by UKAD in partnership with King's College London
More than 100,000 samples have been collected by UK Anti-Doping (UKAD), many of which were processed at the Drug Control Centre (DCC) at King’s Forensics. Testing urine and blood samples from athletes is a key component of keeping sport clean. UKAD was formed in 2009 as the UK’s first independent National Anti-Doping Organisation and collects samples from UK athletes wherever they are in the world, and any athletes training and competing in the UK, such as the recent Tokyo 2020 Olympics.
UKAD renews partnership with King's to test athlete samples for anti-doping purposes
A new six-year contract has been signed between UKAD (UK Anti-Doping) and DCC (The Drug Control Centre), King’s Forensics at King’s, marking a new stage in a longstanding partnership aimed at keeping sport clean. UKAD and DCC have pioneered innovative ways of testing and analysing data. Partnership milestones to date have included boosting detection of human Growth Hormone biomarkers and improving micro-dosing detection.
P004 An evaluation of the management of thrombosis in neonates and infants using dalteparin
Neonatal and Paediatric Pharmacists Conference, Bristol, UK, November 2018 P004 An evaluation of the management of thrombosis in neonates and infants using dalteparin Free Sian Gaze1, Falak Latif2, Kim Wolff2 1Evelina London Children’s Hospital 2King’s College London Abstract Aim To assess the safety and efficacy of the current dalteparin dosing recommendations in achieving therapeutic anti-Xa levels, when used for the treatment of thrombosis in neonates and infants.
Ventilatory Responses to Hypercarbia in Infants of Mothers Who Smoke and Misuse Substances
Publication HistoryPublished Online: May 20, 2016Accepted: April 21, 2016; Received in revised form: April 5, 2016; Received: January 5, 2016;
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Kim
Contact Kim, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack